 |
|
|
|
|
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2022 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
ISM Therapeutics
| | | | | Phone: | (206) 812-1510 | | Fax: | (206) 448-9289 | | Year Established: | 1998 | | Employees: | 5 | | Main Contact: | Alexis Traynor-Kaplan, Ph.D., Founder & CSO | | | | Company Description | | ISM Therapeutics (formerly Inologic) is a biopharmaceutical company with a leadership position in the discovery and development of a new platform of therapeutic drugs based on inositol signaling molecules (ISMs). ISMs are intracellular messengers that affect key signaling pathways linked to many serious diseases. By utilizing a unique and practical approach to discovering new drug leads, ISM Therapeutics has identified a number of drug candidates ranging from discovery research to viable clinical leads, which are currently in development for the treatment of cystic fibrosis, cancer and radioprotection. | |
|
|
|
|
|
|
|
